Amalgamated Bank Sells 373 Shares of Cardinal Health, Inc. (NYSE:CAH)

Amalgamated Bank reduced its position in shares of Cardinal Health, Inc. (NYSE:CAHFree Report) by 0.7% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 52,719 shares of the company’s stock after selling 373 shares during the quarter. Amalgamated Bank’s holdings in Cardinal Health were worth $6,235,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also made changes to their positions in CAH. Frazier Financial Advisors LLC grew its position in shares of Cardinal Health by 69.8% during the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock worth $28,000 after buying an additional 104 shares in the last quarter. Hara Capital LLC bought a new stake in shares of Cardinal Health in the third quarter valued at about $31,000. AM Squared Ltd purchased a new stake in Cardinal Health in the third quarter worth about $33,000. Kentucky Trust Co bought a new position in Cardinal Health during the 4th quarter worth about $41,000. Finally, HHM Wealth Advisors LLC increased its position in Cardinal Health by 57.6% during the 4th quarter. HHM Wealth Advisors LLC now owns 394 shares of the company’s stock valued at $47,000 after purchasing an additional 144 shares during the period. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Stock Down 0.4 %

Shares of Cardinal Health stock opened at $127.31 on Thursday. The company has a 50 day moving average price of $124.31 and a 200 day moving average price of $117.79. The firm has a market capitalization of $30.75 billion, a P/E ratio of 23.75, a PEG ratio of 1.49 and a beta of 0.63. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $132.84.

Cardinal Health (NYSE:CAHGet Free Report) last issued its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a yield of 1.59%. Cardinal Health’s dividend payout ratio is currently 37.69%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on CAH shares. Wells Fargo & Company upped their price target on shares of Cardinal Health from $135.00 to $136.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 4th. Argus set a $148.00 target price on Cardinal Health in a report on Tuesday, February 4th. UBS Group boosted their price target on Cardinal Health from $134.00 to $139.00 and gave the stock a “buy” rating in a research report on Monday, November 4th. Morgan Stanley upped their price objective on Cardinal Health from $136.00 to $142.00 and gave the stock an “overweight” rating in a research note on Friday, January 31st. Finally, TD Cowen upgraded Cardinal Health from a “hold” rating to a “buy” rating and lifted their target price for the company from $130.00 to $144.00 in a research note on Wednesday, January 8th. Four equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat, Cardinal Health currently has a consensus rating of “Moderate Buy” and an average target price of $139.36.

Check Out Our Latest Research Report on CAH

Cardinal Health Profile

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

See Also

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.